Impact of Sarcopenia on Dyspnea in Patients With Asthma

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions

SarcopeniaAsthmaDyspneaDyspnea; AsthmaticCytokinesAdipokinesMyokineMuscle Disorder

Interventions

DIAGNOSTIC_TEST

muscle evaluation

The investigators will evaluate the muscle mass and muscle strenght for all patients included

BIOLOGICAL

Dosage

Evaluation of the cinetic of biomarkers during exercise

DIAGNOSTIC_TEST

Cardiopulmonary exercise test

CPET

COMBINATION_PRODUCT

Questionnaire and Physical Exam

Evaluating dyspnea, anxiety, sleep, physical activity, quality of life

Trial Locations (1)

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors

lead

University Hospital, Clermont-Ferrand

OTHER

NCT06870890 - Impact of Sarcopenia on Dyspnea in Patients With Asthma | Biotech Hunter | Biotech Hunter